Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09KLO
|
|||
Former ID |
DIB007510
|
|||
Drug Name |
AZD-5106
|
|||
Indication | Urinary incontinence [ICD-11: MF50.2; ICD-9: 788.3] | Terminated | [1] | |
Company |
AstraZeneca plc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Substance-K receptor (TACR2) | Target Info | Antagonist | [2] |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Reactome | G alpha (q) signalling events | |||
WikiPathways | Gastrin-CREB signalling pathway via PKC and MAPK | |||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015341) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015341) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.